Marken continues expansion of global footprint

Marken continues expansion of global footprint by adding new depots and additional hubs in the US, Ukraine, the Netherlands, Ireland and Switzerland.

Marken has announced it is are adding a GMP-compliant depot in Los Angeles, California and a new GMP-compliant depot in Kiev, Ukraine. In addition, two GDP-compliant logistics branches will be added in Dublin, Ireland and Amsterdam, the Netherlands. These newest additions to Marken’s global network add increased capacity and is aimed to enable Marken to continue to offer supply chain services to its clients, their investigator sites and patients.

The Amsterdam facility will include a cryogenic filling station to meet the growing need of Marken’s cell and gene therapy clients. An additional LN2 service station has been added to Marken’s network in Geneva, Switzerland.

“The infrastructure investments we have made in all of our facilities globally serve a single purpose,” said Ariette van Strien, Marken’s President. “Since 2011, we have made investments which meet client demands where they need us.  Marken will always strive to offer the very best service, reliability and security for our clients.”

By early Q4, Marken will have 12 fully operational GMP-compliant depot locations, complemented by more than 10m sq ft of GMP-validated commercial warehouse space in 56 UPS Healthcare distribution centres.

Wes Wheeler, UPS Healthcare’s President, commented: “Marken continues to lead as our clinical trial logistics subsidiary with unique new services and a very broad reach.  We will continue to invest in Marken as the industry moves into new regions of the world, becomes more virtual, and demands a greater degree of control and visibility. We are also using their unique knowledge in clinical trials to influence our strategic investments in healthcare.”

Source: Marken